INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Targeted Modalities: Trends, Challenges, CDMO Considerations
Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
-
Meeting 100% Recruitment 7 Months Ahead Of Schedule
Uncover the detailed outcomes of this extensive Phase 3 clinical trial on a new biosimilar for non-small cell lung cancer.
-
A Strategic Framework For Positive Site-Sponsor Relationships
Through an examination of evolving trial strategies and implementation, we aim to lay the groundwork for a collaborative, mutually beneficial atmosphere, ultimately leading to a sustainable competitive edge.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
What Sites Really Want: Insights From The 2024 Site Landscape Survey7/15/2025
Take a closer look at the 2024 SCRS Site Landscape Survey—and what sites say they need most. Less friction. More follow-through. And partners who actually lighten the load.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
-
Harnessing AI for Pre-Award Landscape Analysis And Site Selection1/16/2026
AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.
-
2025 Clinical Trial Payment Tax Implications Explained10/8/2025
Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.
-
More Than Technology: How People Make The Difference For Customers12/11/2025
Technology alone doesn’t guarantee success. Here, we explain how integrated processes, skilled teams, and collaborative partnerships complement innovation to reduce risk and improve patient outcomes.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Comprehensive travel and concierge support removes barriers to clinical trial participation, easing burdens for patients and sites while boosting retention and research outcomes.
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
Streamline trial budgets and payments with real-time fair market data, speeding startups and ensuring timely, transparent site funding worldwide.
-
IQVIA Technologies’ Investigator Site Portal (formerly DrugDev) offers sponsors, CROs, and sites the ability to manage trials easily and efficiently, from beginning to end, by enabling users to communicate effortlessly with sites, design and execute goals, and provide reporting, trial metrics, and much more.